Topics

EU grants conditional marketing authorization to Bayer's Vitrakvi

06:53 EDT 25 Sep 2019 | SmartBrief

Bayer's Vitrakvi, or larotrectinib, was granted conditional marketing authorization by the European Commission for adult and  -More

Original Article: EU grants conditional marketing authorization to Bayer's Vitrakvi

NEXT ARTICLE

More From BioPortfolio on "EU grants conditional marketing authorization to Bayer's Vitrakvi"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...